Related Experiment Video

Updated: Jun 22, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Hepatitis C and poor quality of life: is it the virus or the patient?

Ayman A Abdo1

  • 1Division of Gastroenterology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia. aabdo@ksu.edu.sa

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|July 2, 2009
PubMed

Insights

Hepatitis C virus (HCV) infection causes systemic issues, notably fatigue and psychological distress, significantly reducing patients' quality of life. This review examines the link between HCV, fatigue, and psychological factors impacting health-related quality of life.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Psychosomatic Medicine

Background:

  • Hepatitis C is a systemic viral infection impacting liver health and causing extrahepatic manifestations.
  • Chronic Hepatitis C Virus (HCV) infection frequently leads to significant impairments in health-related quality of life (HRQOL).
  • Fatigue is a prevalent and debilitating extrahepatic symptom in nearly half of individuals with chronic HCV.

Purpose of the Study:

  • To review the association between Hepatitis C Virus (HCV) infection and impaired HRQOL.
  • To explore the impact of fatigue as a key extrahepatic manifestation on patient well-being.
  • To examine the role of psychological disturbances in conjunction with fatigue in diminishing HRQOL for HCV patients.

Main Methods:

  • Literature review of studies investigating Hepatitis C Virus (HCV) and health-related quality of life (HRQOL).
  • Analysis of research focusing on extrahepatic symptoms, particularly fatigue.
  • Examination of studies correlating psychological factors with HRQOL in HCV-infected individuals.

Main Results:

  • Hepatitis C Virus (HCV) infection is linked to a spectrum of extrahepatic manifestations.
  • Fatigue is a primary contributor to poor health-related quality of life (HRQOL) in chronically infected individuals.
  • Psychological factors, alongside physical symptoms like fatigue, significantly worsen HRQOL in Hepatitis C patients.

Conclusions:

  • Hepatitis C Virus (HCV) is a systemic disease with profound effects on quality of life beyond liver damage.
  • Addressing fatigue and psychological disturbances is crucial for improving the overall well-being of patients with Hepatitis C.
  • Interventions targeting extrahepatic symptoms are essential for enhancing health-related quality of life (HRQOL) in Hepatitis C management.

Keywords:
Fatiguehepatitis C virusliverquality of life

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...